Erin L. Russell
Erin L. Russell's purchase track record
Erin L. Russell has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/2/2025 | FTRE | $100K | +27.4% | +4.7% | +6.3% |
| 11/12/2021 | EHTH | $100K | -43.5% | -57.1% | -14.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
eHealth Partners with BerniePortal and Top Medicare Carrier. eHealth announced new partnerships with BerniePortal and a top Medicare carrier to help employers and brokers manage plan enrollment. These moves aim to expand the company's reach in the insurance market as it prepares for the upcoming annual enrollment period. The stock is currently trading near its 52-week low, with an RSI of 20.4 suggesting it is deeply oversold.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Barclays Upgrades Fortrea, Boosts Target to $23. Barclays has upgraded Fortrea Holdings to overweight and lifted its target price to $23. The upgrade follows a recent rise in the stock price and a mention of the company as an overrated pick in a Yahoo article. Analysts still see upside potential, with the average target of $21.04 and a 52‑week range that includes the new level. The stock’s high‑beta rating indicates it may continue to move sharply with market swings.
Transaction History
| KAI | ▲ Buy | Option Exercise | 128 | — | 10/3/2026 | View on chart |
| KAI | ▲ Buy | Option Exercise | 128 | — | 7/4/2026 | View on chart |
| EHTH | ▲ Buy | Grant | 61,041 | $0 | 6/18/2026 | View on chart |
| FTRE | ▲ Buy | Option Exercise | 38,817 | $0 | 6/10/2026 | View on chart |
| KAI | ▲ Buy | Option Exercise | 129 | — | 4/4/2026 | View on chart |
| FTRE | ▲ Buy | Option Exercise | 23,946 | $0 | 3/20/2026 | View on chart |
| KAI | ▲ Buy | Option Exercise | 131 | — | 1/3/2026 | View on chart |
| KAI | ▼ Sell | Open Market | 1,435 | $405K | 11/25/2025 | View on chart |
| KAI | ▲ Buy | Option Exercise | 132 | — | 9/27/2025 | View on chart |
| FTRE | ▲ Buy | Open Market | 9,854 | $100K | 9/2/2025 | View on chart |
| EHTH | ▲ Buy | Grant | 34,574 | $0 | 6/17/2025 | View on chart |
| KAI | ▲ Buy | Option Exercise | 264 | — | 6/1/2025 | View on chart |
| KAI | ▲ Buy | Option Exercise | 151 | — | 12/28/2024 | View on chart |
| KAI | ▲ Buy | Option Exercise | 152 | — | 9/28/2024 | View on chart |
| EHTH | ▲ Buy | Grant | 31,760 | $0 | 6/11/2024 | View on chart |
| KAI | ▲ Buy | Option Exercise | 303 | — | 6/1/2024 | View on chart |
| KAI | ▼ Sell | Open Market | 1,112 | $311K | 5/31/2024 | View on chart |
| KAI | ▲ Buy | Option Exercise | 217 | — | 12/30/2023 | View on chart |
| KAI | ▲ Buy | Option Exercise | 217 | — | 9/30/2023 | View on chart |
| KAI | ▼ Sell | Open Market | 1,250 | $274K | 9/13/2023 | View on chart |
| EHTH | ▲ Buy | Grant | 24,446 | $0 | 6/14/2023 | View on chart |
| KAI | ▲ Buy | Option Exercise | 434 | — | 6/1/2023 | View on chart |
| KAI | ▲ Buy | Option Exercise | 235 | — | 12/31/2022 | View on chart |
| KAI | ▲ Buy | Option Exercise | 235 | — | 10/1/2022 | View on chart |
| EHTH | ▲ Buy | Grant | 16,560 | $0 | 6/15/2022 | View on chart |
| KAI | ▲ Buy | Option Exercise | 471 | — | 6/1/2022 | View on chart |
| KAI | ▲ Buy | Option Exercise | 252 | — | 1/1/2022 | View on chart |
| EHTH | ▲ Buy | Open Market | 3,556 | $100K | 11/12/2021 | View on chart |
| KAI | ▲ Buy | Option Exercise | 252 | — | 10/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Kadant (KAI) Featured in Dividend and Small-Cap Stock Lists
Kadant Inc was highlighted in recent articles discussing dividend stocks and Russell 2000 equities. One piece included KAI in a list of dividend champions, contenders, and challengers, while another identified it as a small-cap stock worth further research. These mentions place the company in the spotlight for investors tracking dividend consistency and smaller market opportunities.
Kadant (KAI) Featured in Dividend and Small-Cap Stock Lists. Kadant Inc was highlighted in recent articles discussing dividend stocks and Russell 2000 equities. One piece included KAI in a list of dividend champions, contenders, and challengers, while another identified it as a small-cap stock worth further research. These mentions place the company in the spotlight for investors tracking dividend consistency and smaller market opportunities.